Position in VCEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,575,400
+$1,760,931 QoQ
Shares Held
170,272
-5.8% QoQ
Ownership
0.333%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#56
of 314 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VCEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Thrivent Financial for Lutherans holds $348,973,073 across 50 Biotechnology names. VCEL ranks #7 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
1,620,743 | $88,184,625 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
131,457 | $81,968,697 | |
| 3 | RPRX |
Royalty Pharma plc
|
740,772 | $41,535,085 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
80,500 | $19,398,084 | |
| 5 | ARGX |
Argenx SE
|
12,688 | $11,771,545 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
20,169 | $10,018,546 | |
| 7 | VCEL |
Vericel Corp
This page
|
170,272 | $7,575,400 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
17,229 | $6,403,502 |
All Filings in VCEL
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,575,400 | 170,272 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $5,814,469 | 180,742 | Shares | Defined | 2026-05-01 | |
| 2025-12-31 | $6,616,152 | 183,731 | Shares | Defined | 2026-02-05 | |
| 2025-09-30 | $6,288,649 | 199,830 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $13,460,223 | 316,339 | Shares | Defined | 2025-08-26 | |
| 2025-03-31 | $14,120,712 | 316,466 | Shares | Defined | 2025-08-26 | |
| 2024-12-31 | $20,198,149 | 367,841 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $17,447,855 | 412,967 | Shares | Defined | 2024-11-07 | |
| 2024-06-30 | $20,604,432 | 449,094 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $24,089,577 | 463,083 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $19,711,060 | 553,526 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $18,479,006 | 551,283 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $11,183,386 | 297,668 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $8,825,466 | 301,005 | Shares | Defined | 2023-05-17 | |
| 2022-12-31 | $7,792,872 | 295,857 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $1,131,440 | 48,769 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,165,682 | 46,294 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $1,456,602 | 38,111 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,497,290 | 38,099 | Shares | Sole | 2022-02-16 | |
| 2021-09-30 | $1,839,369 | 37,692 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,989,540 | 37,896 | Shares | Sole | 2021-09-24 | |
| 2021-03-31 | $2,097,068 | 37,751 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||